Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

CAS for Stenosis With High-risk Features for CEA

NCT: NCT07370246 · RECRUITING

NCT IDNCT07370246
StatusRECRUITING
Start Date2026-03-06
Completion2028-12-31

Brief Summary

The purpose of this prospective, multicenter, single-group target-value study is to evaluate the safety and efficacy of the carotid artery stent system in patients with high-risk features for carotid endarterectomy. This trial is utilizing the carotid artery stent system provided by Shanghai HeartCare Medical Technology Co., Ltd. and will be conducted at approximately 10 interventional neurology centers in China.

Frequently Asked Questions

What is CAS for Stenosis With High-risk Features for CEA?

CAS for Stenosis With High-risk Features for CEA is a clinical trial registered under NCT07370246. Current status: RECRUITING.

What is the status of NCT07370246?

The current status of NCT07370246 (CAS for Stenosis With High-risk Features for CEA) is: RECRUITING.

When did CAS for Stenosis With High-risk Features for CEA start?

CAS for Stenosis With High-risk Features for CEA started on 2026-03-06.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.